Transkingdom Interactions Important for the Pathogenesis of Human Viruses.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
16 06 2021
Historique:
pubmed: 18 12 2020
medline: 2 10 2021
entrez: 17 12 2020
Statut: ppublish

Résumé

The bacterial, fungal, and helminthic species that comprise the microbiome of the mammalian host have profound effects on health and disease. Pathogenic viruses must contend with the microbiome during infection and likely have evolved to exploit or evade the microbiome. Both direct interactions between the virions and the microbiota and immunomodulation and tissue remodeling caused by the microbiome alter viral pathogenesis in either host- or virus-beneficial ways. Recent insights from in vitro and murine models of viral pathogenesis have highlighted synergistic and antagonistic, direct and indirect interactions between the microbiome and pathogenic viruses. This review will focus on the transkingdom interactions between human gastrointestinal and respiratory viruses and the constituent microbiome of those tissues.

Identifiants

pubmed: 33330907
pii: 6039533
doi: 10.1093/infdis/jiaa735
pmc: PMC8206799
doi:

Types de publication

Introductory Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S201-S208

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI106700
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI124302
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI110618
Pays : United States
Organisme : NIAID NIH HHS
ID : R03 AI133527
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI140766
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400006C
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00052
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Int J Parasitol. 2013 Mar;43(3-4):253-7
pubmed: 23178750
Front Immunol. 2018 Oct 09;9:2240
pubmed: 30356736
mSystems. 2020 Sep 1;5(5):
pubmed: 32873612
PLoS Negl Trop Dis. 2020 Aug 17;14(8):e0008628
pubmed: 32804930
Science. 2015 Jan 16;347(6219):266-9
pubmed: 25431490
Microbes Infect. 2012 Mar;14(3):273-8
pubmed: 22079149
Front Immunol. 2019 Jul 03;10:1524
pubmed: 31333658
mSphere. 2017 Oct 11;2(5):
pubmed: 29034326
Blood. 2018 Jun 28;131(26):2978-2986
pubmed: 29674425
Inflamm Bowel Dis. 2014 Mar;20(3):431-43
pubmed: 24487272
Parasite Immunol. 2015 Jun;37(6):304-13
pubmed: 25869527
Science. 2015 Jan 16;347(6219):269-73
pubmed: 25431489
Pediatr Res. 2005 Dec;58(6):1198-203
pubmed: 16306193
Diagn Microbiol Infect Dis. 2011 Aug;70(4):492-8
pubmed: 20846815
Trop Anim Health Prod. 2010 Dec;42(8):1855-60
pubmed: 20623187
Nat Microbiol. 2020 Jan;5(1):84-92
pubmed: 31768030
Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G537-G549
pubmed: 28302598
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):948-52
pubmed: 8094248
Sci Rep. 2016 Nov 22;6:37045
pubmed: 27872472
Nat Microbiol. 2019 Aug;4(8):1328-1336
pubmed: 31110359
Nat Commun. 2020 Apr 29;11(1):2097
pubmed: 32350281
Transpl Infect Dis. 2019 Dec;21(6):e13180
pubmed: 31544324
J Virol. 2012 Nov;86(22):12262-70
pubmed: 22951832
Science. 2014 Nov 14;346(6211):861-5
pubmed: 25395539
Nat Rev Immunol. 2020 Jun;20(6):342
pubmed: 32358579
EBioMedicine. 2016 Nov;13:46-54
pubmed: 27863931
Science. 2011 Oct 14;334(6053):245-9
pubmed: 21998394
World J Gastrointest Pharmacol Ther. 2017 Aug 6;8(3):162-173
pubmed: 28828194
Nature. 1987 Feb 5-11;325(6104):536-7
pubmed: 3543690
Science. 2011 Oct 14;334(6053):249-52
pubmed: 21998395
Gastroenterology. 1998 Jan;114(1):115-22
pubmed: 9428225
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5354-9
pubmed: 21402903
Nat Rev Microbiol. 2004 Aug;2(8):618-9
pubmed: 15303271
FASEB J. 2006 Oct;20(12):2121-3
pubmed: 16914605
Exp Parasitol. 1972 Aug;32(1):33-44
pubmed: 5065669
PLoS One. 2014 Nov 14;9(11):e112469
pubmed: 25398130
J Immunol. 2013 Aug 1;191(3):1250-9
pubmed: 23804714
J Virol. 2013 Jun;87(12):7015-31
pubmed: 23596300
J Clin Gastroenterol. 2011 Nov;45 Suppl:S149-53
pubmed: 21992955
Science. 2014 Aug 1;345(6196):578-82
pubmed: 25082704
J Virol. 2019 Nov 13;93(23):
pubmed: 31511379
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Diagn Microbiol Infect Dis. 2018 Jun;91(2):147-152
pubmed: 29454654
Science. 2014 Nov 7;346(6210):755-9
pubmed: 25378626
Cell. 2019 Oct 17;179(3):644-658.e13
pubmed: 31607511
Science. 2014 Aug 1;345(6196):573-7
pubmed: 24968940
J Immunol. 1995 Nov 1;155(9):4497-503
pubmed: 7594613
J Allergy Clin Immunol. 2017 Oct;140(4):1068-1078.e6
pubmed: 28196762
Gut Microbes. 2012 Sep-Oct;3(5):463-7
pubmed: 22825498
PLoS Med. 2015 Jan 06;12(1):e1001776
pubmed: 25562317
J Virol. 2019 Oct 29;93(22):
pubmed: 31462558
J Pathog. 2012;2012:971958
pubmed: 23326669
Cell Host Microbe. 2014 Jan 15;15(1):36-46
pubmed: 24439896
Nat Commun. 2018 Oct 30;9(1):4516
pubmed: 30375396
Virus Res. 2005 Jun;110(1-2):1-8
pubmed: 15845250
mBio. 2020 Feb 18;11(1):
pubmed: 32071269
Infect Immun. 2006 Mar;74(3):1924-32
pubmed: 16495568
Cell Rep. 2020 Mar 3;30(9):2934-2947.e6
pubmed: 32130898
Nat Commun. 2019 Jul 22;10(1):3273
pubmed: 31332169
J Trop Pediatr. 2016 Dec;62(6):464-470
pubmed: 27283364
Nat Microbiol. 2019 Aug;4(8):1316-1327
pubmed: 31110357
Front Microbiol. 2018 May 29;9:1110
pubmed: 29896176
PLoS Pathog. 2020 Feb 27;16(2):e1008240
pubmed: 32106253
Am J Respir Cell Mol Biol. 2012 Feb;46(2):127-31
pubmed: 21980056
Front Microbiol. 2018 Apr 03;9:630
pubmed: 29666617
J Antimicrob Chemother. 2011 Nov;66(11):2444-7
pubmed: 21816766
PLoS One. 2013 Jun 17;8(6):e66019
pubmed: 23799070
Sci Rep. 2019 Mar 1;9(1):3199
pubmed: 30824789
J Infect Dis. 2020 Apr 7;221(9):1448-1461
pubmed: 31875228
Respir Res. 2016 Jun 03;17(1):68
pubmed: 27259950
J Infect Dis. 2002 Aug 1;186(3):341-50
pubmed: 12134230
mSphere. 2019 Feb 20;4(1):
pubmed: 30787120

Auteurs

Andrew Nishimoto (A)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Nicholas Wohlgemuth (N)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Jason Rosch (J)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Stacey Schultz-Cherry (S)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Valerie Cortez (V)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Hannah M Rowe (HM)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH